Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.020 | 5.020 | 0.000 |
Shares | 94.980 | 94.980 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.939 | 21.748 |
Price to Book | 4.565 | 4.013 |
Price to Sales | 2.962 | 2.262 |
Price to Cash Flow | 16.249 | 16.964 |
Dividend Yield | 2.173 | 1.339 |
5 Years Earnings Growth | 9.366 | 11.136 |
Number of long holdings: 36
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 7.67 | 87.97 | -1.01% | |
Merck & Co Inc | - | 6.34 | - | - | |
AstraZeneca | GB0009895292 | 5.89 | 12,050.0 | -0.87% | |
Edwards Lifesciences Corp | - | 4.97 | - | - | |
Novo Nordisk A/S B | DK0060534915 | 4.90 | - | - | |
Roche Holding Participation | CH0012032048 | 4.77 | 217.30 | +1.49% | |
Boston Scientific Corp | - | 4.65 | - | - | |
Eli Lilly and Co | - | 4.49 | - | - | |
Medtronic | IE00BTN1Y115 | 4.42 | 81.68 | +0.94% | |
Pfizer Inc | - | 3.97 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IKC Taktisk Allokering 0 100 | 2.91B | 17.76 | 9.12 | 9.78 | ||
IKC Sverige Flexibel | 1.71B | 8.59 | 5.07 | 13.83 | ||
IKC Lux 0 100 IC | 973.54M | 16.97 | 7.50 | 7.35 | ||
IKC Fastighetsfond A | 392.08M | 3.82 | 2.72 | - | ||
IKC Fastighetsfond B | 392.08M | 3.90 | 3.12 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review